Definium Therapeutics (DFTX) Goodwill & Intangibles (2021 - 2026)

Definium Therapeutics (DFTX) has 6 years of Goodwill & Intangibles data on file, last reported at $19.9 million in Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $19.9 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.9 million (changed 0.0% YoY), and the FY2025 annual result was $19.9 million, changed 0.0% from the prior year.
• Goodwill & Intangibles steadied at $19.9 million in Q1 2026 per DFTX's latest filing, from $19.9 million in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $26.0 million in Q1 2022 and troughed at $19.9 million in Q1 2024.
• A 5-year average of $21.5 million and a median of $19.9 million in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2023 and 2025: Goodwill & Intangibles declined 13.39% in 2023, then changed 0.0% in 2025.
• A 5-year view of Goodwill & Intangibles shows it stood at $23.6 million in 2022, then declined by 13.39% to $20.4 million in 2023, then declined by 2.58% to $19.9 million in 2024, then changed by 0.0% to $19.9 million in 2025, then changed by 0.0% to $19.9 million in 2026.
• Business Quant data shows DFTX's Goodwill & Intangibles at $19.9 million in Q1 2026, $19.9 million in Q4 2025, and $19.9 million in Q3 2025.